Celltrion USA announces submission of the Biologics License Application (BLA) of novel subcutaneous formulation of CT-P13 to U.S. Food and Drug Administration
CHICAGO--(BUSINESS WIRE)--Dec 22, 2022--
Source: wsiltv.com
Novel Formulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Novel Formulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Novel Formulation Today - Breaking & Trending Today
Jupiter Neurosciences, Inc. Announces Journal of Alzheimer's Disease Publication Highlighting use of JOTROL™
/PRNewswire/ -- Jupiter Neurosciences, Inc. ("Jupiter" or the "Company"), today announced the publication in the Journal of Alzheimer's Disease of "JOTROL™, a...
Source: prnewswire.com
New data show statistically greater improvements in clinical outcomes with subcutaneous infliximab, compared to intravenous infliximab, in patients wi
New data show statistically greater improvements in clinical outcomes with subcutaneous infliximab, compared to intravenous infliximab, in patients with rheumatoid arthritis· Presented today at EULAR 2022, data from a new post-hoc analysis show a statistically signifi...
Source: pharmiweb.com
Celltrion Healthcare: New Data Show Statistically Greater Improvements in Clinical Outcomes with Subcutaneous Infliximab, Compared to Intravenous Infliximab, in Patients With Rheumatoid Arthritis
Presented today at EULAR 2022, data from a new post-hoc analysis show a statistically significant difference in clinical outcomes with subcutaneous (SC) infliximab compared to intravenous (IV) infliximab
Source: finanznachrichten.de
Three natural ingredient research articles from holidays
Researchers are publishing new information on potential naturally-derived ingredients every day, including when everyone else is distracted by holidays.
Source: cosmeticsdesign.com